CAH
CAH
US14149Y1082
Cardinal Health, Inc.
Loading chart...

Company Profile

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Latest News

Related stocks

COR
COR • United States
Cencora, Inc.
323.85 USD
61.8B USD 1Y +3.5%
MCK
MCK • United States
McKesson Corporation
938.84 USD
109.46B USD 1Y +23.1%
HSIC
HSIC • United States
Henry Schein, Inc.
84.01 USD
9.57B USD 1Y +30.7%
SIG.AX
SIG.AX • Australia
SIGMAHEALT FPO [SIG]
2.69 AUD
21.62B USD 1Y -10.9%
BSX
BSX • United States
Boston Scientific Corporation
42.73 USD
61.93B USD 1Y -56.6%
601607.SS
601607.SS • China
SHANGHAI PHARMACEUTICALS HOLDIN
16.68 CNY
9.26B USD 1Y -8.8%
1099.HK
1099.HK • China
SINOPHARM
14.87 HKD
5.91B USD 1Y -20.5%
HUM
HUM • United States
Humana Inc.
431.87 USD
51.86B USD 1Y +29.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
5Y Volatility
24.8% p.a.
Max Drawdown (5Y)
-20.9%
Sharpe Ratio (5Y)
1.41
Beta Factor
0.50
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Historical Stress Test: Maximum peak-to-trough drawdown of -51.1% in the extended horizon.
ende